Abstract. Diffuse Large B-Cell Lymphoma (DLBCL) is a clinically and biologically heterogeneous disease. The revised Classification of Lymphoproliferative diseases published in 2016 (WHO. 2016) refined the previous DLBLC subtypes and identified four categories: DLBCL not otherwise specified (NOS). https://www.lightemupsequences.com/